See also this year's filing and all EDGAR filings for this company.
PDF Report 0001626971_2023_Corvus_Pharmaceuticals_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001626971, Corvus Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 43,664,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 353,000 |
| 3 | remainder_Assets | 24,223,000 |
| 4 | LiabilitiesCurrent | 10,752,000 |
| 5 | LiabilitiesNoncurrent | 1,373,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 8,097,000 |
| 9 | ResearchAndDevelopmentExpense | 24,468,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -8,742,000 |
| 13 | remainder_ComprehensiveNetIncome | -2,432,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 68,240,000 |
| 1 | Liabilities | 12,125,000 |
| 2 | Expenses | 32,565,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 56,115,000 |
| 5 | NetIncome | -41,307,000 |
| 6 | ComprehensiveNetIncome | -42,523,000 |
| 7 | BaseVar | 62,052,000 |
| 8 | EconomicCapitalRatio | 1.34 |
Edgar->Model Mapping
Feature Distribution
Change over Time
